DCT

1:11-cv-01077

Novartis Pharma Corp v. Par Pharmaceutical Inc

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

Please sign up or log in to access the advanced features of
Ex Parte Enterprise.

General

Filed

11/03/11

Cause of ActionInfringement

SectorBiotech

Status

Closed (09/17/14)

Patent Owner

Operating Company (W)

PACER

Appeals

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Judge	Period	PO Win Rate
Richard G. Andrews	03/09/12 - 07/31/17	50%
Sue L. Robinson	11/09/11 - 03/09/12	50%

Plaintiff

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

Name	Ratings
Novartis Pharmaceuticals Corp	-- -- --
LTS Lohmann Therapie Systeme AG	L1 C

No Parties

Attorney

Name	Ratings
McCarter & English LLP	L5 A
Patrick J. Coyne	L5 A
Neal S. Cohen	L5 A
Peter Kinsella	L5 A
Greenberg Traurig LLP	L5 A
Scott E. Holwick	L5 A
Fitzpatrick Cella Harper & Scinto	L5 A
Robert D. Bajefsky	L5 A
Scott J. Popma	L5 A
Jennifer S. Swan	L5 A
Aaron M. Raphael	L5 A
Hugh S. Balsam	L5 A

No Attorneys

Defendant

Please sign up or log in to access the advanced features of
Ex Parte Professional.

Party

No Parties

Attorney

Name	Ratings
Latham & Watkins LLP	L5 A
Patrick J. Coyne	L5 A
Scott E. Holwick	L5 A
Scott J. Popma	L5 A
Angie M. Hankins	L5 A
Young Conaway Stargatt & Taylor LLPLocal	L5 A
Neal S. Cohen	L5 A
Aaron M. Raphael	L5 A
Marc R. Labgold	L5 A
Michael J. Schaengold	L5 A
Proctor Heyman LLPLocal	L5 A
Peter Kinsella	L5 A
Vinson & Elkins LLP	L5 A
Robert D. Bajefsky	L5 A
Jennifer S. Swan	L5 A
Lisa A. Jakob	L5 A
Jackson Walker LLPLocal	L5 A
Hugh S. Balsam	L5 A
Rothwell Figg Ernst & Manbeck	L5 A
David A. Nelson	L5 A
Timothy J. Schutz	L5 A
Kevin M. Bell	L5 A
Robert J. Koch	L5 A
Richards Layton & Finger PALocal	L5 A
Steven M. Bauer	L5 A
Richard W. Hanes	L5 A

No Attorneys